Evidence map›Paper›PMID 30122154›Full record

ArticleEpigenetics & chromatin2018

Sporadic DUX4 expression in FSHD myocytes is associated with incomplete repression by the PRC2 complex and gain of H3K9 acetylation on the contracted D4Z4 allele.

Premi Haynes, Karol Bomsztyk, Daniel G Miller

Open access · goldAbstract read
In one paragraph

Article in Epigenetics & chromatin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. IncreasedInternational journal of molecular sciences · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Chromosome 10q-linked FSHD identifiesJournal of medical genetics · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Premi HaynesDepartments of Pediatrics and Genome Sciences, University of Washington, Seattle, WA, USA.
Karol BomsztykDepartment of Medicine, University of Washington, Seattle, WA, USA.
Daniel G MillerDepartments of Pediatrics and Genome Sciences, University of Washington, Seattle, WA, USA. dgmiller.uw@gmail.com.
University of Washington · US

Funding

Mechanisms of megakaryocyte maturationR01DK094934 · NIDDK · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2012 to 2016
$2.7M
Next generation technology to detect epigenetic alterations in human tissuesR33CA191135 · NCI · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL · 2015 to 2017
$1.3M
Integrated microplate platform for epigenetic analysisR21GM111439 · NIGMS · UNIVERSITY OF WASHINGTON · PI BOMSZTYK, KAROL · 2014 to 2016
$601k
Chromatin Modifications that modulate DUX4 expression in FSHDR56AR070778 · NIAMS · UNIVERSITY OF WASHINGTON · PI MILLER, DANIEL G · 2017 to 2017
$440k
NCI NIH HHS R33 CA191135NIAMS NIH HHS R01 AR06419701A1NIAMS NIH HHS R56 AR070778NIDDK NIH HHS R01 DK094934NIGMS NIH HHS R21 GM111439NIH HHS R01 DK094934NIH HHS R21 GM111439NIH HHS R33 CA191135
6 · The paper itself

Abstract

backgroundFacioscapulohumeral muscular dystrophy 1 (FSHD1) has an autosomal dominant pattern of inheritance and primarily affects skeletal muscle. The genetic cause of FSHD1 is contraction of the D4Z4 macrosatellite array on chromosome 4 alleles associated with a permissive haplotype causing infrequent sporadic expression of the DUX4 gene. Epigenetically, the contracted D4Z4 array has decreased cytosine methylation and an open chromatin structure. Despite these genetic and epigenetic changes, the majority of FSHD myoblasts are able to repress DUX4 transcription. In this study we hypothesized that histone modifications distinguish DUX4 expressing and non-expressing cells from the same individuals.

resultsFSHD myocytes containing the permissive 4qA haplotype with a long terminal D4Z4 unit were sorted into DUX4 expressing and non-expressing groups. We found similar CpG hypomethylation between the groups of FSHD-affected cells suggesting that CpG hypomethylation is not sufficient to trigger DUX4 expression. A survey of histone modifications present at the D4Z4 region during cell lineage commitment revealed that this region is bivalent in FSHD iPS cells with both H3K4me3 activating and H3K27me3 repressive marks present, making D4Z4 poised for DUX4 activation in pluripotent cells. After lineage commitment, the D4Z4 region becomes univalent with H3K27me3 in FSHD and non-FSHD control myoblasts and a concomitant increase in H3K4me3 in a small fraction of cells. Chromatin immunoprecipitation (ChIP) for histone modifications, chromatin modifier proteins and chromatin structural proteins on sorted FSHD myocytes revealed that activating H3K9Ac modifications were ~ fourfold higher in DUX4 expressing FSHD myocytes, while the repressive H3K27me3 modification was ~ fourfold higher at the permissive allele in DUX4 non-expressing FSHD myocytes from the same cultures. Similarly, we identified EZH2, a member of the polycomb repressive complex involved in H3K27 methylation, to be present more frequently on the permissive allele in DUX4 non-expressing FSHD myocytes.

conclusionsThese results implicate PRC2 as the complex primarily responsible for DUX4 repression in the setting of FSHD and H3K9 acetylation along with reciprocal loss of H3K27me3 as key epigenetic events that result in DUX4 expression. Future studies focused on events that trigger H3K9Ac or augment PRC2 complex activity in a small fraction of nuclei may expose additional drug targets worthy of study.

Indexed as

Protein Processing, Post-TranslationalAcetylationCells, CulturedChromatin Assembly and DisassemblyHistonesHomeodomain ProteinsHumansMuscle CellsMuscular Dystrophy, FacioscapulohumeralPolycomb Repressive Complex 2DUX4L1 protein, humanHistonesHomeodomain ProteinsPolycomb Repressive Complex 2BivalentChromatinD4Z4DUX4DystrophyEpigeneticsFacioscapulohumeralFSHDH3K9AcHistoneMuscularNeuromuscularPolycomb repressive complexPRC2SMCHD1

Identifiers

PMID30122154
PMCPMC6100714
OpenAlexW2888513008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.